234 related articles for article (PubMed ID: 33324422)
1. Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey.
van de Ven AAJM; Alfaro TM; Robinson A; Baumann U; Bergeron A; Burns SO; Condliffe AM; Fevang B; Gennery AR; Haerynck F; Jacob J; Jolles S; Malphettes M; Meignin V; Milota T; van Montfrans J; Prasse A; Quinti I; Renzoni E; Stolz D; Warnatz K; Hurst JR
Front Immunol; 2020; 11():606333. PubMed ID: 33324422
[TBL] [Abstract][Full Text] [Related]
2. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
Jolles S; Carne E; Brouns M; El-Shanawany T; Williams P; Marshall C; Fielding P
Clin Exp Immunol; 2017 Jan; 187(1):138-145. PubMed ID: 27896807
[TBL] [Abstract][Full Text] [Related]
3. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
Chase NM; Verbsky JW; Hintermeyer MK; Waukau JK; Tomita-Mitchell A; Casper JT; Singh S; Shahir KS; Tisol WB; Nugent ML; Rao RN; Mackinnon AC; Goodman LR; Simpson PM; Routes JM
J Clin Immunol; 2013 Jan; 33(1):30-9. PubMed ID: 22930256
[TBL] [Abstract][Full Text] [Related]
4. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
[TBL] [Abstract][Full Text] [Related]
5. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
[TBL] [Abstract][Full Text] [Related]
6. Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers.
Cinetto F; Scarpa R; Carrabba M; Firinu D; Lougaris V; Buso H; Garzi G; Gianese S; Soccodato V; Punziano A; Lagnese G; Tessarin G; Costanzo G; Landini N; Vio S; Bondioni MP; Consonni D; Marasco C; Del Giacco S; Rattazzi M; Vacca A; Plebani A; Fabio G; Spadaro G; Agostini C; Quinti I; Milito C
Front Immunol; 2021; 12():627423. PubMed ID: 33777011
[No Abstract] [Full Text] [Related]
7. Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review.
Lamers OAC; Smits BM; Leavis HL; de Bree GJ; Cunningham-Rundles C; Dalm VASH; Ho HE; Hurst JR; IJspeert H; Prevaes SMPJ; Robinson A; van Stigt AC; Terheggen-Lagro S; van de Ven AAJM; Warnatz K; van de Wijgert JHHM; van Montfrans J
Front Immunol; 2021; 12():606099. PubMed ID: 33936030
[TBL] [Abstract][Full Text] [Related]
8. GLILD Revisited: Pulmonary Pathology of Common Variable and Selective IgA Immunodeficiency.
Larsen BT; Smith ML; Tazelaar HD; Yi ES; Ryu JH; Churg A
Am J Surg Pathol; 2020 Aug; 44(8):1073-1081. PubMed ID: 32235152
[TBL] [Abstract][Full Text] [Related]
9. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.
Mannina A; Chung JH; Swigris JJ; Solomon JJ; Huie TJ; Yunt ZX; Truong TQ; Brown KK; Achcar RD; Olson AL; Cox CW; Kligerman SJ; Curran-Everett D; Fernández Pérez ER
Ann Am Thorac Soc; 2016 Jul; 13(7):1042-9. PubMed ID: 27064856
[TBL] [Abstract][Full Text] [Related]
10. Granulomatous lymphocytic interstitial lung disease: description of a series of 9 cases.
Ruiz-Alcaraz S; Gayá García-Manso I; Marco-De La Calle FM; García-Mullor MDM; López-Brull H; García-Sevila R
Med Clin (Barc); 2021 Apr; 156(7):344-348. PubMed ID: 33478812
[TBL] [Abstract][Full Text] [Related]
11. Common variable immunodeficiency-associated granulomatous and interstitial lung disease.
Prasse A; Kayser G; Warnatz K
Curr Opin Pulm Med; 2013 Sep; 19(5):503-9. PubMed ID: 23880700
[TBL] [Abstract][Full Text] [Related]
12. Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.
Fraz MSA; Michelsen AE; Moe N; Aaløkken TM; Macpherson ME; Nordøy I; Aukrust P; Taraldsrud E; Holm AM; Ueland T; Jørgensen SF; Fevang B
J Clin Immunol; 2022 Oct; 42(7):1553-1563. PubMed ID: 35789314
[TBL] [Abstract][Full Text] [Related]
13. Granulomatous Lymphocytic Interstitial Lung Disease in a Spectrum of Pediatric Primary Immunodeficiencies.
Szczawinska-Poplonyk A; Jonczyk-Potoczna K; Mikos M; Ossowska L; Langfort R
Pediatr Dev Pathol; 2021; 24(6):504-512. PubMed ID: 34176349
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus as an alternative treatment in patients with granulomatous-lymphocytic lung disease and humoral immunodeficiency with impaired regulatory T cells.
Deyà-Martínez A; Esteve-Solé A; Vélez-Tirado N; Celis V; Costa J; Cols M; Jou C; Vlagea A; Plaza-Martin AM; Juan M; Alsina L
Pediatr Allergy Immunol; 2018 Jun; 29(4):425-432. PubMed ID: 29532571
[TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis and common variable immunodeficiency: similarities and differences.
Verbsky JW; Routes JM
Semin Respir Crit Care Med; 2014 Jun; 35(3):330-5. PubMed ID: 25007085
[TBL] [Abstract][Full Text] [Related]
16. Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.
Pathria M; Urbine D; Zumberg MS; Guarderas J
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335365
[TBL] [Abstract][Full Text] [Related]
17. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
Cowen JE; Stevenson J; Paravasthu M; Darroch J; Jacob A; Tueger S; Gosney JR; Simons A; Spencer LG; Judge EP
BMC Pulm Med; 2020 Jul; 20(1):205. PubMed ID: 32736614
[TBL] [Abstract][Full Text] [Related]
18. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.
Tashtoush B; Memarpour R; Ramirez J; Bejarano P; Mehta J
Clin Respir J; 2018 Jan; 12(1):337-343. PubMed ID: 27243233
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review.
Bintalib HM; van de Ven A; Jacob J; Davidsen JR; Fevang B; Hanitsch LG; Malphettes M; van Montfrans J; Maglione PJ; Milito C; Routes J; Warnatz K; Hurst JR
Front Immunol; 2023; 14():1190235. PubMed ID: 37223103
[TBL] [Abstract][Full Text] [Related]
20. Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.
Ng J; Wright K; Alvarez M; Hunninghake GM; Wesemann DR
Chest; 2019 May; 155(5):e117-e121. PubMed ID: 31060706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]